TauRx Pharmaceuticals (HK) Limited

TauRx Pharmaceutical (HK) Ltd is a commercial-stage biopharmaceutical company dedicated to developing innovative solutions for neurodegenerative diseases associated with pathological protein aggregation. Through decades of scientific innovation, TauRx has advanced hydromethylthionine mesylate (HMTM), a novel tau-directed therapy designed to modify disease progression rather than simply manage symptoms.The expansion of our presence at Hong Kong Science Park reflects TauRx's commitment to advancin